AI-generated summary
The authors randomized 71 patients with melasma to twice-weekly yellow light phototherapy with either 20% vitamin C or a vehicle. At week 12, the vitamin C combination group showed greater improvement on the mMASI and PGA scores and melanin index, though the absolute mMASI reduction was modest. No adverse events were reported.
- Participants
- 71
- Who or what was studied
- Patients with melasma
- Limits stated in the abstract
- The abstract reports a single-center trial with a modest absolute reduction in mMASI, and it does not describe wavelengths or any long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Placebo-controlled, Phototherapy, Melanin, Primary outcome, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.